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Abstract
Placenta accreta is a life-threatening obstetrical condition. Prenatal prediction of placenta 
accreta helps to minimize clinical complications. Placenta previa is one of the most impor-
tant factors associated with placenta accreta. In our prospective cohort study, ultrasound 
finding of loss of the retroplacental hypoechoic clear zone was found to be a single predic-
tor of placenta accreta in women with placenta previa (odds ratio, 15.6; 95% confidence 
interval, 2.1–114.6; p < 0.01). In addition, we have devised a novel scoring system for 
predicting placenta accreta in pregnancy with placenta previa, yielding 91.3% sensitivity, 
98.0% specificity, 87.5% positive predictive value, and 98.7% negative predictive value. 
Planned preterm cesarean hysterectomy with the placenta left in situ is generally recom-
mended for women with suspicion of placenta accreta. If the women have a desire for 
future fertility, conservative approach may be considered.
Keywords: cesarean section, placenta accreta, prenatal diagnosis, placenta previa, 
scoring system
1. Introduction
Placenta accreta is a life-threatening obstetrical condition. Clinical complications of placenta 
accreta involve massive hemorrhage, damage to adjacent organs, cesarean hysterectomy, 
and maternal death. Placenta previa is one of the most important risk factors for placenta 
accreta [1]. Prenatal prediction of placenta accreta helps to minimize clinical complications by 
enabling obstetricians to plan for resources that may be required during cesarean delivery, 
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including obstetric anesthesia, appropriate surgical expertise, available blood products, and 
interventional radiology for uterine artery embolization [2, 3]. Therefore, accurate prenatal 
prediction of placenta accreta in women with placenta previa is important.
This review will focus on the recent knowledge regarding the prenatal diagnosis and manage-
ment of placenta accreta in women with placenta previa.
2. The prenatal prediction of placenta accreta in women with 
placenta previa
2.1. Ultrasonography
It has been reported that ultrasonography is the most useful method for diagnosing placenta 
accreta. Previous studies have demonstrated that ultrasound (US) findings involving the 
presence of placental lacunae (PL) [4], an anterior myometrial thickening [5], loss of the ret-
roplacental hypoechoic clear zone (LCZ) [6], anomalies of the bladder-myometrium interface 
[7], and the presence of turbulent blood flow (TBF) in the arteries radiating from the placenta 
toward the uterine serosa, detected by color Doppler [8] are associated with placenta accreta. 
However, these previous results were based on retrospective studies for pregnant women 
with and without placenta previa.
In the prospective study, we aimed to determine more effective imaging for predicting pla-
centa accreta in women with placenta previa using stepwise logistic regression analyses [9]. 
Univariate logistic regression analyses demonstrated that US findings of anterior placental 
location (odds ratio [OR], 5.1; 95% confidence interval [CI], 1.2–20.5; p < 0.05), grade 2 or 
higher PL (PL ≥ G2) (OR, 17.0; 95%CI, 4.0–71.1; p < 0. 01), LCZ (OR, 49.4; 95% CI, 8.5–2862; 
p < 0.01), and magnetic resonance imaging (MRI) (OR, 24.6; 95% CI, 4.7–129.2; p < 0.01) were 
associated with placenta accreta. Multivariable analyses revealed that LCZ (OR, 15.6; 95%CI, 
2.1–114.6; p < 0.01) was a single significant predictor of placenta accreta in women with pla-
centa previa [9]. In this study, LCZ yielded 86.7% sensitivity, 88.4% specificity, 72.2% posi-
tive predictive value (PPV), and 95.0% negative predictive value (NPV) for the prediction of 
placenta accreta in women with placenta previa. In contrast, a previous study found that LCZ 
had low PPV for predicting placenta accreta, because LCZ is often observed among women 
with anterior placental location during normal pregnancy [10]. However, the previous study 
enrolled women who had anterior placental location and a history of cesarean section (CS); if 
the subjects were limited to women with placenta previa, diagnostic accuracy of LCZ might 
be improved.
Recently, we demonstrated that a novel US finding referred to as an “irregular sign” might 
be useful for predicting placenta accreta in women with placenta previa [11]. The irregular 
sign is defined as the irregularity of the border between the placenta and the myometrium 
around internal uterine os observed by transvaginal ultrasonography (Figure 1). The pres-
ence of irregular sign yielded 56.5% sensitivity, 99.3% specificity, 92.9% PPV, and 93.8% NPV 
for predicting placenta accreta in women with placenta previa [11].
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2.2. Magnetic resonance imaging
Some investigators suggested that MRI was a useful tool for diagnosing placenta accreta 
prenatally [12, 13]. MRI findings suggestive of placenta accreta included indistinctness or the 
absence of myometrial wall at the placental site, loss of the thin T2 dark uteroplacental interface, 
a nodular interface between the placenta and the uterus, a mass effect of the placenta on the 
uterus causing uterine outer bulge, heterogeneous signal intensity within the placenta, dark 
intraplacental bands on T2-weighted images, and abnormal dilated venous lakes within the 
placenta [13–15]. MRI provided advantages in diagnosing placenta accreta in women who had 
posterior placental location [16]. We found that MRI was selected as a significant finding in 
predicting placenta accreta in pregnant women with placenta previa by univariate analyses in 
the prospective study (OR, 24.6; 95% CI, 4.7–129.2; p < 0.01) [9].
However, other investigators claimed that MRI was more expensive and invasive examination 
than US; therefore, US should be the diagnostic modality of first choice for placenta accreta, 
and MRI was not always necessary [17]. Dynamic contrast-enhanced MRI with gadolinium 
(Gd) is not recommended at any time during pregnancy, because the use of Gd increases the 
risk of a broad set of rheumatological, inflammatory, or infiltrative skin conditions and of 
stillbirth or neonatal death [18].
2.3. Diagnostic scoring systems
Diagnostic scoring systems may be more useful than a single US finding for predicting placenta 
accreta in women with a history of previous CS, placenta previa, or low-lying placenta [19–21]. 
These scoring systems include several US findings suggestive of placenta accreta, the presence 
of placenta previa, and the number of prior CS. Optimal cut-off values of these scores deter-
mined in the retrospective or prospective studies yielded 72.0–94.2% sensitivity, 52.5–85.0% 
specificity, 63.4–70.0% PPV, and 86.0–100% NPV for the prediction of placenta accreta [19–21].
Figure 1. (A) The presence of the irregular sign in a case with placenta accreta. (B) The absence of the irregular sign in a 
case without placenta accreta. Dashed white marks indicate the border between the placenta and myometrium around 
internal uterine os [11].
Management of Placenta Accreta in Pregnancy with Placenta Previa
http://dx.doi.org/10.5772/intechopen.79185
87
We devised a novel scoring system for predicting placenta accreta in women with placenta 
previa, and in a prospective cohort study evaluated the diagnostic efficacy of this scoring 
system named the placenta previa with adherent placenta (PPAP) score [11]. The PPAP score 
is composed of two categories: (1) past history of CS, surgical abortion, and/or uterine surgery 
and (2) US and MRI findings. Each category is graded as 0, 1, 2, or 4 points, yielding a total 
score between 0 and 24 (Table 1).
Women with placenta previa who had PPAP score ≥ 8 were considered to be at a high risk for 
placenta accreta. The PPAP score yielded 91.3% sensitivity, 98.0% specificity, 87.5% PPV, and 
98.7% NPV for predicting placenta accreta in women with placenta previa [11]. However, the 
Variables Level of variable Score
Past history
Number of previous CS 0 0
1 2
≥ 2 4




Other uterine surgery No 0
Present 2




USG Grade of placental lacunae 0 0
1 2
≥ 2 4
Loss of clear zone Absent 0
Equivocal 2
Present 4
Turbulent blood flow Absent 0
Equivocal 1
Present 2
Irregular sign Absent 0
Present 2
MRI Suspicious of placenta accreta No 0
Yes 2
PPAP, placenta previa with adherent placenta; CS, cesarean section; USG, ultrasonography; and MRI, magnetic resonance 
imaging.
Table 1. The variables and scores in the PPAP scoring system.
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PPAP scoring failed to predict two women with placenta accreta. One woman had a history 
of myomectomy and PPAP score of 6 and another had a past history of myometrium resection 
for adenomyosis and PPAP score of 4. The presence of a history of myomectomy and myome-
trium resection for adenomyosis seems to increase the risk for placenta accreta in women who 
had PPAP score < 8. Special attention should be paid to the risk of placenta accreta regardless 
of US or MRI findings.
3. The management of placenta accreta in women with placenta 
previa
All pregnant women with placenta previa suspected to have placenta accreta should be man-
aged at specialized tertiary centers [22]. Their deliveries should be performed by an experienced 
medical team consisted of obstetric surgeons, urologists, general surgeons, and gynecologic 
oncologists [23]. Planned cesarean hysterectomy decreases the morbidity and mortality rates in 
women complicated by placenta accreta [3]. The timing of delivery in such women must be indi-
vidualized; however, a recent study suggested that delivery at 34 weeks of gestation (GW) in 
stable women with placenta accreta optimized the outcomes of both mothers and neonates [24].
The anesthesiologists should assess which anesthetic techniques are used before delivery. 
Both general and regional anesthetic techniques are available, and the decision of which type 
of technique to be used should be made on an individual basis [23]. Preoperative cystoscopy 
with placement of ureteral stents may help prevent accidental urinary tract injury. In addi-
tion, sufficient amount of blood products should be available in the operating room.
Planned preterm cesarean hysterectomy with the placenta left in situ is generally recom-
mended for women with suspicion of placenta accreta, because forced removal of the placenta 
causes massive hemorrhage. Midline vertical incision may be considered because it provides 
sufficient exposure if hysterectomy is needed. CS using transverse uterine fundal incision 
method is often used to avoid the placenta and allow delivery of the infant.
Hysterectomy is performed in the usual fashion. In some cases with anterior placenta accreta, 
especially in cases with placenta percreta, partial resection of the bladder wall is necessary. On 
the other hand, if the women have a strong desire for future fertility, conservative approach, 
i.e. leaving the placenta in situ, may be considered. However, a review, which summarized 
the conservative management of 60 women with placenta accreta, showed that infection 
occurred in 11 of the 60 women (18%), bleeding in 21 (35%), and disseminated intravascular 
coagulation in 4 (7%) [25]. Therefore, this conservative approach should be considered only 
when women are willing to accept the risks involved in this approach.
There has been lack of sufficient evidence for beneficial effects of prophylactic catheter place-
ment for balloon occlusion or artery embolization [26–28] as well as treatment with metho-
trexate [29–31] . Therefore, a firm recommendation on the use of these procedures cannot be 
made [23, 31]. It is difficult to establish evidence-based management strategies for placenta 
accreta in pregnancy with placenta previa. Therefore, clinicians should manage these women 
by suitable approaches in each medical institution.
Management of Placenta Accreta in Pregnancy with Placenta Previa
http://dx.doi.org/10.5772/intechopen.79185
89
Figure 2 shows an algorithm used in the Kobe University Hospital for the management of 
pregnant women with placenta previa. All pregnant women with placenta previa receive 
workup for placenta accreta in inpatient or outpatient care. If women have bleeding, they are 
hospitalized immediately and receive intravenous administration of tocolytic agents such as 
magnesium sulfate or β-stimulant. Even if they do not have bleeding, they are hospitalized 
at 32–34GW. Women have a PPAP score ≥ 8, who are suspected of having placenta accreta, 
receive both preoperative internal iliac artery occlusion balloon catheters placement and elec-
tive CS at 35–37GW.
Figure 3 shows a flow algorithm used in the Kobe University Hospital for the preoperative 
preparation and operative procedures for women with suspicion of placenta accreta. Women 
with placenta previa had a PPAP score ≥ 8, who were suspected of having placenta accreta, 
received preoperative internal iliac artery occlusion balloon catheters placement. After fetal 
delivery by a CS using transverse uterine fundal incision method, the internal iliac artery occlu-
sion balloon catheters were inflated. After occlusion of the artery, local injection of oxytocin into 
the myometrium and uterine massage were performed to induce spontaneous placental sepa-
ration. If placental separation did not occur at all and women did not have a desire for future 
fertility, cesarean hysterectomy was performed. When the placenta was not partially separated, 
partial resection of uterine wall or removal of placenta using advanced bipolar was performed.
Figure 2. An algorithm for the management of pregnant women with placenta previa. MRI, magnetic resonance imaging; 
GW, weeks of gestation; NRFS, non-reassuring fetal status; and CS, cesarean section.
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